JP2023522177A5 - - Google Patents
Info
- Publication number
- JP2023522177A5 JP2023522177A5 JP2022561449A JP2022561449A JP2023522177A5 JP 2023522177 A5 JP2023522177 A5 JP 2023522177A5 JP 2022561449 A JP2022561449 A JP 2022561449A JP 2022561449 A JP2022561449 A JP 2022561449A JP 2023522177 A5 JP2023522177 A5 JP 2023522177A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- substituted
- carbon atom
- group
- atoms
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063007650P | 2020-04-09 | 2020-04-09 | |
| US202063007660P | 2020-04-09 | 2020-04-09 | |
| US63/007,650 | 2020-04-09 | ||
| US63/007,660 | 2020-04-09 | ||
| PCT/US2021/026316 WO2021207453A1 (en) | 2020-04-09 | 2021-04-08 | Compounds for treating huntington's disease |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023522177A JP2023522177A (ja) | 2023-05-29 |
| JP2023522177A5 true JP2023522177A5 (https=) | 2024-04-18 |
| JP7799618B2 JP7799618B2 (ja) | 2026-01-15 |
Family
ID=75747091
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022561449A Active JP7799618B2 (ja) | 2020-04-09 | 2021-04-08 | ハンチントン病を処置するための化合物 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20230234942A1 (https=) |
| EP (1) | EP4132923A1 (https=) |
| JP (1) | JP7799618B2 (https=) |
| KR (1) | KR20230009367A (https=) |
| CN (1) | CN115768762A (https=) |
| AU (1) | AU2021254418A1 (https=) |
| BR (1) | BR112022020147A2 (https=) |
| CA (1) | CA3173903A1 (https=) |
| IL (1) | IL297044A (https=) |
| MX (1) | MX2022012575A (https=) |
| WO (1) | WO2021207453A1 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11407753B2 (en) | 2017-06-05 | 2022-08-09 | Ptc Therapeutics, Inc. | Compounds for treating Huntington's disease |
| MX2020009957A (es) | 2018-03-27 | 2021-01-15 | Ptc Therapeutics Inc | Compuestos para el tratamiento de enfermedad de hungtinton. |
| PL3814357T3 (pl) | 2018-06-27 | 2024-09-16 | Ptc Therapeutics, Inc. | Związki heterocykliczne i heteroarylowe do leczenia choroby huntingtona |
| EP3814345B8 (en) | 2018-06-27 | 2024-10-30 | PTC Therapeutics, Inc. | Heteroaryl compounds for treating huntington's disease |
| WO2020231977A1 (en) * | 2019-05-13 | 2020-11-19 | Ptc Therapeutics, Inc. | Compounds for treating huntington's disease |
| BR112022023025A2 (pt) | 2020-05-13 | 2023-03-28 | Chdi Foundation Inc | Moduladores de htt para tratar doença de huntington |
| US12281116B2 (en) | 2021-11-17 | 2025-04-22 | Chdi Foundation, Inc. | HTT modulators for treating Huntington's disease |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8729263B2 (en) * | 2012-08-13 | 2014-05-20 | Novartis Ag | 1,4-disubstituted pyridazine analogs there of and methods for treating SMN-deficiency-related conditions |
| IL294124B2 (en) * | 2015-12-10 | 2024-02-01 | Ptc Therapeutics Inc | Methods for treating huntington's disease |
| MX2020009957A (es) | 2018-03-27 | 2021-01-15 | Ptc Therapeutics Inc | Compuestos para el tratamiento de enfermedad de hungtinton. |
| PL3814357T3 (pl) * | 2018-06-27 | 2024-09-16 | Ptc Therapeutics, Inc. | Związki heterocykliczne i heteroarylowe do leczenia choroby huntingtona |
| WO2020231977A1 (en) * | 2019-05-13 | 2020-11-19 | Ptc Therapeutics, Inc. | Compounds for treating huntington's disease |
-
2021
- 2021-04-08 MX MX2022012575A patent/MX2022012575A/es unknown
- 2021-04-08 IL IL297044A patent/IL297044A/en unknown
- 2021-04-08 CN CN202180039608.3A patent/CN115768762A/zh active Pending
- 2021-04-08 EP EP21722671.1A patent/EP4132923A1/en active Pending
- 2021-04-08 CA CA3173903A patent/CA3173903A1/en active Pending
- 2021-04-08 BR BR112022020147A patent/BR112022020147A2/pt not_active Application Discontinuation
- 2021-04-08 KR KR1020227034422A patent/KR20230009367A/ko not_active Withdrawn
- 2021-04-08 WO PCT/US2021/026316 patent/WO2021207453A1/en not_active Ceased
- 2021-04-08 AU AU2021254418A patent/AU2021254418A1/en active Pending
- 2021-04-08 JP JP2022561449A patent/JP7799618B2/ja active Active
- 2021-04-08 US US17/917,450 patent/US20230234942A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023522177A5 (https=) | ||
| RU2353616C2 (ru) | Производные 2-пиридона в качестве ингибиторов эластазы нейтрофилов и их применение | |
| RU2375363C2 (ru) | Пирролотриазиновые производные анилина, полезные в качестве ингибиторов киназы | |
| RU2336275C2 (ru) | Пиримидопроизводные, характеризующиеся антипролиферативной активностью, и фармацевтическая композиция | |
| TWI579284B (zh) | 咪唑并吡咯啶酮化合物 | |
| JP6524081B2 (ja) | ジヒドロピリミジン化合物及び医薬におけるその適用 | |
| RU2350605C2 (ru) | Аналоги хиназолина в качестве ингибиторов рецепторных тирозинкиназ | |
| JP2001526269A5 (https=) | ||
| CN114401952A (zh) | 作为整合应激通路的调节剂的被取代的环烷基化合物 | |
| JP2023520925A5 (https=) | ||
| JP2009538910A5 (https=) | ||
| JP2010536887A5 (https=) | ||
| JP2019510787A5 (https=) | ||
| JP2005538100A5 (https=) | ||
| RU2014152790A (ru) | Пирролопиразоновые ингибиторы танкиразы | |
| JP2011509309A5 (https=) | ||
| JP2011500758A5 (https=) | ||
| JP2010523522A5 (https=) | ||
| JP2004529140A5 (https=) | ||
| JP2021502387A5 (https=) | ||
| JP2010510999A5 (https=) | ||
| JP2013542261A5 (https=) | ||
| JP2015504067A5 (https=) | ||
| RU2002130252A (ru) | Замещенные амиды бензойной кислоты и их применение для подавления ангиогенеза | |
| RU2009139915A (ru) | Производные имидазолидинона |